Alliance Growers Corp., reports that it has executed a definitive exclusive agency agreement with Irish Sea Organics.
Alliance Growers Corp. (CSE:ACG, FWB:1LA, OTCQB:ALGWF) (“Alliance Growers” or “the Company), reports that it has executed a definitive exclusive agency agreement with Irish Sea Organics (“Irish Sea”).
Irish Sea is a company established to promote the benefits of electrolyzed water/Hypochlorous Acid (“HOCL”) that is used in the various processes in the industrial, agricultural and healthcare sectors. Irish Sea has developed a process utilizing HOCL that is specific for the cultivation of pharmaceutical grade cannabis crops and can be used in the cultivation of hemp as well. Irish Sea delivers a combination of specialized and integrated equipment, consumables, services and consultancy which provide significant economic and efficacy benefits to cultivation, processing, extraction and packaging sectors in the agricultural sector where mold, pests, microbial control is vital.
Subject to compliance with relevant Canadian Cannabis laws and regulations, Alliance Growers has been granted the exclusive rights to market, promote and sell Irish Sea Organics’ products and services in Canada. The definitive agreement was finalized on September 10, 2019 and solidifies the terms of the advanced discussions between Alliance Growers and Irish Sea Organics, which were reported in a news release on August 21, 2019. The agreement is for a term of 60 months to be reviewed after 48 months
This agreement with Irish Sea Organics is a significant step for Alliance Growers to demonstrate to investors that the company is executing on its strategy of providing products and services to cultivators rather than competing with them,” stated Dennis Petke, President and CEO of Alliance Growers. We are well-aware that cannabis investors are seeking investments in the cannabis space that offer the opportunity for near term revenues. That, along with our low market cap and low stock price make Alliance a vey attractive investment. “Irish Sea Organics provides a premier solution to many key issues facing the cannabis industry today and fits perfectly with our “picks and shovels” strategy in the green rush. “Irish Sea Organics is a well-run company with a high-quality management team with over 75 years experience among them in health care, medical devices, research and international operations. They bring with them a revolutionary product offering that will add great value to companies in the agriculture and cannabis sectors, a technology furthers our goal of establishing a long-term presence in the cannabis industry through diversity, science and technology. We thank our many loyal shareholders and other stakeholders for their continued support “
Irish Sea Organics breakthrough technology is revolutionizing seed, plant, harvest, drying and raw material extraction processes. Cannabis companies will reassess their cleaning and disinfecting processes and how they can protect their crops against mould and spores. This highly effective green technology is without toxicity.
HOCL production equipment and the unique applications are used for high-volume, industrial and commercial applications, specifically bacteria, mould, and spore control. The introduction of HOCL to any size of cultivation or processing business operation, combines proven efficacy and performance with vital cost benefits to the end user.
The Irish Sea Organics product is already being employed by Coca-Cola company in several US beverage processing plants, and successful installations for clean in place (“CIP”) have shown excellent ROI figures, whilst contributing to improved sustainability goals. Processing Magazine recently reviewed Coca-Cola’s use of this game changing technology for CIP.
Mould, sporicidal and pest attrition is a major problem for the domestic cannabis industry in Canada but is an even more serious issue for Canadian companies wishing to export globally. Canada, as a global leader in the cannabis market, is expected to be at the forefront of emerging cannabis markets and this technology will assist in that endeavour.
Graeme Smith, CEO of Irish Sea Organics states, “This is a natural progression for Irish Sea Organics and Alliance Growers as the Alliance Growers’ team already have wide-ranging experience in the cannabis sector in Canada. We share the same principles as well as a philosophy to provide the production of unique, safe, and quality products. We’ve already established a multi-year plan and we’re preparing for a strong push into Canada to capitalize on the tremendous market opportunities in the appropriate sectors.”
Alliance Growers also announces that it has made the determination that it is not in the best interests of the Company to proceed with its previously announced acquisition of BioCannaTech Inc. Instead of the cultivation of cannabis, the Company has made is committed to advance opportunities that will provide better value to the Company’s shareholders and stakeholders.
About Irish Sea Organics
Irish Sea Organics breakthrough technology is revolutionizing seed, plant, harvest, drying and raw material extraction processes. Hypochlorous water or HOCL is electrolyzed water manufactured by the human body that is used by white blood cells to eliminate waste and destroy foreign substances like bacteria, fungus and viruses. There is no known resistance of any organism to its effects, and there are demonstrated kill rates for this product that are FDA and EPA registered and certified. For further information on the Irish Sea Organics, please visit the company’s website at www.irishseaorganics.com/ .
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex (products and services to cultivators), Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. to jointly develop and operate a 63,000-square foot Cannabis Biotech Complex, to be the first of its kind in Western Canada to house a DNA Botany lab, CBD extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general.
If you would like to be added to Alliance Growers’ news distribution list, please send your email address to firstname.lastname@example.org.
For more information contact:
CEO, President and Director
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.